èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã Mersana Therapeutics, Inc. ã¯ãæºããããŠããªãããŒãºãæã€ããæ£è
ã®ããã®æäœè¬ç©è€åäœ (ADC) ã®éçºã«æ³šåããŠããŸããå瀟ã¯ãåµå·£ããããã³éå°çްèèºãã (NSCLC) è
ºããã®æ£è
ã®æ²»çãç®çãšãã第 I çžèšåºè©Šéšäžã® NaPi2b ãæšçãšãã Dolaflexin ADC ã§ãã XMT-1536 ãšãåµå·£ããããã³ NSCLC è
ºããã®æ²»çãç®çãšãã第 I çžèšåºè©Šéšäžã® NaPi2b çºçŸè
«çãæšçãšãã Dolasynthen ADC ã§ãã XMT-1592 ãéçºããŠããŸããå瀟ã¯ãŸããB7-H4 ãæšçãšãã Dolasynthen ADC åè£ã§ãã XMT-1660 ãšãå
ç«åæéçºåè£ã§ãã XMT-2056 ãéçºããŠããŸããå瀟ã¯ãFleximer ãå©çšãã ADC 補ååè£ã®éçºã«é¢ããŠãMerck KGaA ããã³ Asana BioSciences, LLC ãšæŠç¥çç ç©¶éçºããŒãããŒã·ãããçµãã§ããŸããå瀟ã¯ä»¥å㯠Nanopharma Corp. ãšããŠç¥ãããŠããŸãããã2005 幎 11 æã« Mersana Therapeutics, Inc. ã«ç€Ÿåã倿ŽããŸãããMersana Therapeutics, Inc. 㯠2001 幎ã«èšç«ãããããµãã¥ãŒã»ããå·ã±ã³ããªããžã«æ¬ç€Ÿã眮ããŠããŸãã